Multi-syndrome, Multi-gene Risk Modeling for Individuals with a Family History of Cancer with the Novel R Package PanelPRO
Authors
Affiliations
Identifying individuals who are at high risk of cancer due to inherited germline mutations is critical for effective implementation of personalized prevention strategies. Most existing models focus on a few specific syndromes; however, recent evidence from multi-gene panel testing shows that many syndromes are overlapping, motivating the development of models that incorporate family history on several cancers and predict mutations for a comprehensive panel of genes. We present PanelPRO, a new, open-source R package providing a fast, flexible back-end for multi-gene, multi-cancer risk modeling with pedigree data. It includes a customizable database with default parameter values estimated from published studies and allows users to select any combinations of genes and cancers for their models, including well-established single syndrome BayesMendel models (BRCAPRO and MMRPRO). This leads to more accurate risk predictions and ultimately has a high impact on prevention strategies for cancer and clinical decision making. The package is available for download for research purposes at https://projects.iq.harvard.edu/bayesmendel/panelpro.
Impact of population screening for Lynch syndrome insights from the All of Us data.
Park J, Karnati H, Rustgi S, Hur C, Kong X, Kastrinos F Nat Commun. 2025; 16(1):523.
PMID: 39788943 PMC: 11718231. DOI: 10.1038/s41467-024-52562-5.
Bayesian meta-analysis of penetrance for cancer risk.
Ruberu T, Braun D, Parmigiani G, Biswas S Biometrics. 2024; 80(2).
PMID: 38819308 PMC: 11140851. DOI: 10.1093/biomtc/ujae038.
Meta-Analysis of Breast Cancer Risk for Individuals with PALB2 Pathogenic Variants.
Ruberu T, Braun D, Parmigiani G, Biswas S medRxiv. 2023; .
PMID: 37398422 PMC: 10312825. DOI: 10.1101/2023.05.31.23290791.
Combining Breast Cancer Risk Prediction Models.
Guan Z, Huang T, McCarthy A, Hughes K, Semine A, Uno H Cancers (Basel). 2023; 15(4).
PMID: 36831433 PMC: 9953824. DOI: 10.3390/cancers15041090.
Knapp S, Revette A, Underhill-Blazey M, Stopfer J, Ukaegbu C, Poulin C Cancers (Basel). 2023; 15(2).
PMID: 36672340 PMC: 9856567. DOI: 10.3390/cancers15020391.